Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency.

Cancer metastasis is an inefficient process. The steps in metastasis responsible for this inefficiency and how metastatic inefficiency can vary in different locations within an organ remain poorly understood. B16F10 cells were injected to target mouse lung, and at sequential times thereafter we quantified in lung the time course of: (a) overall cell survival and metastatic development; and (b) local cell survival and growth with respect to the lung surface and specific interior structures. We found high rates of initial survival of cells trapped in the lung circulation, extravasation into lung tissue, and subsequent survival of extravasated solitary cells (74% at day 3) before metastasis formation. However, at the time of initial replication of metastatic cells a major loss of cells occurred. Although only a small proportion of injected cells started to form metastases, most of these developed into macroscopic tumors. Solitary cells found at later times were dormant. Thus, overall metastatic inefficiency was largely due to postextravasation events affecting solitary cells. Regionally within the lung, cells and metastases were randomly distributed to day 4, but by day 10 preferential tumor growth was found along the lung surface and around arterial and venous vessels. Thus, trapping and early growth of injected cells was unaffected by location within the lung, whereas subsequent metastatic growth was enhanced in specific microenvironments. This study: (a) quantifies early temporal and spatial progression of metastasis in lung; (b) documents persistence of solitary dormant cells; and (c) shows that metastatic inefficiency depends on the initiation of growth in a subset of extravasated cells, whereas continued growth of metastases occurs preferentially in specific tissue environments.

[1]  P. Steeg,et al.  Angiogenesis and colonization in the tumor metastatic process: basic and applied advances , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  I. Macdonald,et al.  Intravital videomicroscopy of the chorioallantoic microcirculation: a model system for studying metastasis. , 1992, Microvascular research.

[3]  R. Khokha,et al.  Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. , 1995, Cancer research.

[4]  V. Howard,et al.  Unbiased Stereology: Three-Dimensional Measurement in Microscopy , 1998 .

[5]  Joanne L. Martin,et al.  A Retrospective , 1988 .

[6]  C. Culling,et al.  Cellular Pathology Technique , 1985 .

[7]  D. Kp B16 metastases in mouse liver and lung. II. Morphology. , 1988 .

[8]  B. Zbar,et al.  Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by southern hybridization. , 1987, Journal of the National Cancer Institute.

[9]  J E Talmadge,et al.  Evidence for the clonal origin of spontaneous metastases. , 1982, Science.

[10]  I. Fidler Biological behavior of malignant melanoma cells correlated to their survival in vivo. , 1975, Cancer research.

[11]  E. Weibel Practical methods for biological morphometry , 1979 .

[12]  E. Thunnissen,et al.  B16 melanoma metastases in mouse liver and lung. I. Localization. , 1985, Invasion & metastasis.

[13]  R. Khokha,et al.  Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[15]  G. Naumov,et al.  Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. , 1999, Journal of cell science.

[16]  R. Khokha,et al.  Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. , 1994, Cancer research.

[17]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[18]  I. Macdonald,et al.  Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liver. , 1996, Cancer research.

[19]  L. Weiss,et al.  Metastatic inefficiency. , 1990, Advances in cancer research.

[20]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.